News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
A perfect protocol and a well‑funded budget means very little if eligible volunteers never make it through the...
Sofia, Bulgaria, April 28, 2025 – Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe,...
Clinical trials are the backbone of medical advancements, they ensure that new treatments undergo rigorous evaluation for safety...